Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concurrent JE and Measles Vaccine in Infants
NCT00249769Phase 3Completed
- Sponsor
- PATH
- Start
- Nov 2005
- Primary completion
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of japanese encephalitis vaccine sa14-14-2 in Japanese encephalitis (JE), sponsored by PATH. Started Nov 2005; status: completed.
02
Drugs
japanese encephalitis vaccine sa14-14-2
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT00249769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00249769.